$STAA
STAAR Surgical Co Stock $staa

$staa Overview Financials Valuation SEC Filings Company Website

2014 Q2 Form 10-Q Financial Statement

#000114420414029780 Filed on May 13, 2014

Income Statement

Concept	2014 Q2	2013 Q1
Revenue	$20.18M	$18.00M
YoY Change	11.09%	16.07%
Cost Of Revenue	$6.294M	$5.347M
YoY Change	13.53%	16.06%
Gross Profit	$13.88M	$12.65M
YoY Change	10.02%	16.08%
Gross Profit Margin	68.81%	70.3%
Selling, General & Admin	$11.53M	$9.244M
YoY Change	20.37%	8.46%
% of Gross Profit	83.07%	73.05%
Research & Development	$3.484M	$1.366M
YoY Change	106.64%	-11.64%
% of Gross Profit	25.09%	10.8%
Depreciation & Amortization	$453.0K	$369.0K
YoY Change	-21.9%	16.4%
% of Gross Profit	3.26%	2.92%
Operating Expenses	$15.02M	$10.61M
YoY Change	33.28%	5.37%
Operating Profit	-$1.342M	$1.084M
YoY Change	-293.37%	289.93%
Interest Expense	$33.00K	$83.00K
YoY Change	-19.51%	-12.63%
% of Operating Profit		7.66%
Other Income/Expense, Net	$202.0K	-$299.0K
YoY Change	10.38%	-260.75%
Pretax Income	-$1.140M	$785.0K
YoY Change	-229.99%	69.18%
Income Tax	$219.0K	$314.0K
% Of Pretax Income		40.0%
Net Earnings	-$1.359M	$471.0K
YoY Change	-588.85%	103.02%
Net Earnings / Revenue	-6.74%	2.62%
Basic Earnings Per Share	-$0.04	$0.01
Diluted Earnings Per Share	-$0.04	$0.01
COMMON SHARES
Basic Shares Outstanding	37.79M shares	36.43M shares
Diluted Shares Outstanding	37.79M shares	37.42M shares

Balance Sheet

Concept	2014 Q2	2013 Q1
SHORT-TERM ASSETS
Cash & Short-Term Investments	$21.10M	$19.20M
YoY Change	7.11%	17.07%
Cash & Equivalents	$21.07M	$19.24M
Short-Term Investments
Other Short-Term Assets	$989.0K	$2.700M
YoY Change	70.81%	3.85%
Inventory	$13.80M	$11.00M
Prepaid Expenses	$2.820M
Receivables	$11.10M	$8.600M
Other Receivables	$700.0K	$0.00
Total Short-Term Assets	$51.10M	$41.60M
YoY Change	16.63%	8.04%
LONG-TERM ASSETS
Property, Plant & Equipment	$8.800M	$6.200M
YoY Change	43.16%	48.65%
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets	$1.300M	$1.200M
YoY Change	24.88%	5.73%
Total Long-Term Assets	$13.20M	$11.10M
YoY Change	21.64%	11.94%
TOTAL ASSETS
Total Short-Term Assets	$51.10M	$41.60M
Total Long-Term Assets	$13.20M	$11.10M
Total Assets	$64.30M	$52.70M
YoY Change	17.62%	8.84%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable	$6.200M	$3.700M
YoY Change	62.77%	20.05%
Accrued Expenses	$4.900M	$3.400M
YoY Change	32.43%	6.25%
Deferred Revenue
YoY Change
Short-Term Debt	$4.800M	$5.300M
YoY Change	-5.88%	120.83%
Long-Term Debt Due	$300.0K	$700.0K
YoY Change	-40.0%	-22.22%
Total Short-Term Liabilities	$18.30M	$15.20M
YoY Change	18.68%	21.56%
LONG-TERM LIABILITIES
Long-Term Debt	$100.0K	$300.0K
YoY Change	-66.67%	-57.14%
Other Long-Term Liabilities	$2.900M	$3.600M
YoY Change	-12.12%	-2.47%
Total Long-Term Liabilities	$3.000M	$3.900M
YoY Change	-16.67%	5.66%
TOTAL LIABILITIES
Total Short-Term Liabilities	$18.30M	$15.20M
Total Long-Term Liabilities	$3.000M	$3.900M
Total Liabilities	$23.10M	$20.00M
YoY Change	15.47%	13.01%
SHAREHOLDERS EQUITY
Retained Earnings
YoY Change
Common Stock
YoY Change
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity	$41.30M	$32.60M
YoY Change
Total Liabilities & Shareholders Equity	$64.30M	$52.70M
YoY Change	17.62%	8.84%

Cashflow Statement

Concept	2014 Q2	2013 Q1
OPERATING ACTIVITIES
Net Income	-$1.359M	$471.0K
YoY Change	-588.85%	103.02%
Depreciation, Depletion And Amortization	$453.0K	$369.0K
YoY Change	-21.9%	16.4%
Cash From Operating Activities	-$2.590M	-$430.0K
YoY Change	-427.85%	-1.6%
INVESTING ACTIVITIES
Capital Expenditures	$1.414M	$1.218M
YoY Change	-276.75%	324.39%
Acquisitions
YoY Change
Other Investing Activities		$0.00
YoY Change		-100.0%
Cash From Investing Activities	-$1.410M	-$1.220M
YoY Change	76.25%	672.15%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities	2.140M	-220.0K
YoY Change	210.14%	-134.27%
NET CHANGE
Cash From Operating Activities	-2.590M	-430.0K
Cash From Investing Activities	-1.410M	-1.220M
Cash From Financing Activities	2.140M	-220.0K
Net Change In Cash	-1.860M	-1.870M
YoY Change	-373.53%	-4078.72%
FREE CASH FLOW
Cash From Operating Activities	-$2.590M	-$430.0K
Capital Expenditures	$1.414M	$1.218M
Free Cash Flow	-$4.004M	-$1.648M
YoY Change	-351.82%	127.62%

Facts In Submission

Frame	Concept Type	Concept / XBRL Key	Value	Unit
CY2013Q1	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	821000	USD
CY2014Q2	us-gaap	Inventory Raw Materials InventoryRawMaterials	1281000	USD
CY2014Q2	us-gaap	Inventory Work In Process InventoryWorkInProcess	1032000	USD
CY2014Q2	us-gaap	Inventory Finished Goods InventoryFinishedGoods	12448000	USD
CY2014Q2	us-gaap	Inventory Gross InventoryGross	14761000	USD
CY2014Q2	us-gaap	Inventory Valuation Reserves InventoryValuationReserves	976000	USD
CY2014Q2	staa	Estimated Forfeiture Rate EstimatedForfeitureRate	0.0692	pure
CY2014Q1	us-gaap	Finite Lived Intangible Assets Gross FiniteLivedIntangibleAssetsGross	13074000	USD
CY2014Q2	us-gaap	Finite Lived Intangible Assets Gross FiniteLivedIntangibleAssetsGross	13107000	USD
CY2014Q1	us-gaap	Finite Lived Intangible Assets Accumulated Amortization FiniteLivedIntangibleAssetsAccumulatedAmortization	11694000	USD
CY2014Q2	us-gaap	Finite Lived Intangible Assets Accumulated Amortization FiniteLivedIntangibleAssetsAccumulatedAmortization	11819000	USD
CY2014Q1	us-gaap	Accrued Salaries Current AccruedSalariesCurrent	1630000	USD
CY2014Q2	us-gaap	Accrued Salaries Current AccruedSalariesCurrent	2691000	USD
CY2014Q1	us-gaap	Accrued Bonuses Current AccruedBonusesCurrent	935000	USD
CY2014Q2	us-gaap	Accrued Bonuses Current AccruedBonusesCurrent	583000	USD
CY2014Q1	us-gaap	Other Employee Related Liabilities Current And Noncurrent OtherEmployeeRelatedLiabilitiesCurrentAndNoncurrent	731000	USD
CY2014Q2	us-gaap	Other Employee Related Liabilities Current And Noncurrent OtherEmployeeRelatedLiabilitiesCurrentAndNoncurrent	837000	USD
CY2014Q1	us-gaap	Inventory Raw Materials InventoryRawMaterials	1367000	USD
CY2014Q1	us-gaap	Inventory Work In Process InventoryWorkInProcess	913000	USD
CY2014Q1	us-gaap	Inventory Finished Goods InventoryFinishedGoods	11029000	USD
CY2014Q1	us-gaap	Inventory Gross InventoryGross	13309000	USD
CY2014Q1	us-gaap	Inventory Valuation Reserves InventoryValuationReserves	795000	USD
CY2014Q1	us-gaap	Value Added Tax Receivable Current ValueAddedTaxReceivableCurrent	618000	USD
CY2014Q2	us-gaap	Value Added Tax Receivable Current ValueAddedTaxReceivableCurrent	681000	USD
CY2014Q1	us-gaap	Accrued Insurance Current AccruedInsuranceCurrent	551000	USD
CY2014Q2	us-gaap	Accrued Insurance Current AccruedInsuranceCurrent	373000	USD
CY2014Q1	us-gaap	Accrued Professional Fees Current AccruedProfessionalFeesCurrent	328000	USD
CY2014Q2	us-gaap	Accrued Professional Fees Current AccruedProfessionalFeesCurrent	231000	USD
CY2014Q1	us-gaap	Accrued Income Taxes Current AccruedIncomeTaxesCurrent	485000	USD
CY2014Q2	us-gaap	Accrued Income Taxes Current AccruedIncomeTaxesCurrent	173000	USD
CY2014Q1	us-gaap	Other Accrued Liabilities Current OtherAccruedLiabilitiesCurrent	1184000	USD
CY2014Q2	us-gaap	Other Accrued Liabilities Current OtherAccruedLiabilitiesCurrent	1262000	USD
CY2014Q1	us-gaap	Other Assets Current OtherAssetsCurrent	366000	USD
CY2014Q1	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	60000000	shares
CY2014Q1	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.01
CY2014Q2	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.01
CY2014Q1	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	37911000	shares
CY2014Q2	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	38123000	shares
CY2014Q2	us-gaap	Other Assets Current OtherAssetsCurrent	989000	USD
CY2014Q2	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	60000000	shares
CY2014Q1	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	37911000	shares
CY2014Q2	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	38123000	shares
CY2014Q1	us-gaap	Machinery And Equipment Gross MachineryAndEquipmentGross	16225000	USD
CY2014Q2	us-gaap	Machinery And Equipment Gross MachineryAndEquipmentGross	17011000	USD
CY2014Q1	us-gaap	Furniture And Fixtures Gross FurnitureAndFixturesGross	4837000	USD
CY2014Q2	us-gaap	Furniture And Fixtures Gross FurnitureAndFixturesGross	4980000	USD
CY2014Q1	us-gaap	Leasehold Improvements Gross LeaseholdImprovementsGross	6552000	USD
CY2014Q2	us-gaap	Leasehold Improvements Gross LeaseholdImprovementsGross	7516000	USD
CY2014Q1	us-gaap	Property Plant And Equipment Gross PropertyPlantAndEquipmentGross	27614000	USD
CY2014Q2	us-gaap	Property Plant And Equipment Gross PropertyPlantAndEquipmentGross	29507000	USD
CY2014Q1	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	20209000	USD
CY2014Q2	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	20675000	USD
CY2014Q2	us-gaap	Defined Benefit Plan Service Cost DefinedBenefitPlanServiceCost	116000	USD
CY2013Q1	us-gaap	Defined Benefit Plan Service Cost DefinedBenefitPlanServiceCost	124000	USD
CY2014Q2	us-gaap	Defined Benefit Plan Interest Cost DefinedBenefitPlanInterestCost	35000	USD
CY2013Q1	us-gaap	Defined Benefit Plan Interest Cost DefinedBenefitPlanInterestCost	27000	USD
CY2014Q2	us-gaap	Defined Benefit Plan Expected Return On Plan Assets DefinedBenefitPlanExpectedReturnOnPlanAssets	27000	USD
CY2013Q1	us-gaap	Defined Benefit Plan Expected Return On Plan Assets DefinedBenefitPlanExpectedReturnOnPlanAssets	23000	USD
CY2013Q1	us-gaap	Weighted Average Number Of Shares Common Stock Subject To Repurchase Or Cancellation WeightedAverageNumberOfSharesCommonStockSubjectToRepurchaseOrCancellation	36660000	shares
CY2013Q1	us-gaap	Weighted Average Number Of Shares Restricted Stock WeightedAverageNumberOfSharesRestrictedStock	233000	shares
CY2013Q1	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	36427000	shares
CY2014Q2	us-gaap	Incremental Common Shares Attributable To Call Options And Warrants IncrementalCommonSharesAttributableToCallOptionsAndWarrants	0	shares
CY2014Q2	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	37794000	shares
CY2014Q2	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.04
CY2014Q2	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.04
CY2014Q2	us-gaap	Sales Revenue Net SalesRevenueNet	20178000	USD
CY2014Q2	us-gaap	Cost Of Goods And Services Sold CostOfGoodsAndServicesSold	6294000	USD
CY2014Q2	us-gaap	Gross Profit GrossProfit	13884000	USD
CY2014Q2	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	5396000	USD
CY2014Q2	us-gaap	Selling And Marketing Expense SellingAndMarketingExpense	6138000	USD
CY2014Q2	staa	Medical Device Tax MedicalDeviceTax	40000	USD
CY2014Q2	us-gaap	Other General Expense OtherGeneralExpense	168000	USD
CY2014Q2	us-gaap	Operating Income Loss OperatingIncomeLoss	-1342000	USD
CY2014Q2	us-gaap	Investment Income Interest InvestmentIncomeInterest	9000	USD
CY2014Q2	us-gaap	Interest Expense InterestExpense	33000	USD
CY2014Q2	us-gaap	Foreign Currency Transaction Gain Loss Before Tax ForeignCurrencyTransactionGainLossBeforeTax	66000	USD
CY2014Q2	us-gaap	Other Nonoperating Income OtherNonoperatingIncome	160000	USD
CY2014Q2	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	202000	USD
CY2014Q2	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-1140000	USD
CY2014Q2	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	219000	USD
CY2013Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate	0.0061	pure
CY2013Q1	us-gaap	Defined Benefit Plan Actuarial Gain Loss DefinedBenefitPlanActuarialGainLoss	-5000	USD
CY2014Q2	us-gaap	Defined Benefit Plan Net Periodic Benefit Cost DefinedBenefitPlanNetPeriodicBenefitCost	130000	USD
CY2013Q1	us-gaap	Defined Benefit Plan Net Periodic Benefit Cost DefinedBenefitPlanNetPeriodicBenefitCost	136000	USD
CY2014Q2	us-gaap	Defined Benefit Plan Amortization Of Transition Obligations Assets DefinedBenefitPlanAmortizationOfTransitionObligationsAssets	0	USD
CY2013Q1	us-gaap	Defined Benefit Plan Amortization Of Transition Obligations Assets DefinedBenefitPlanAmortizationOfTransitionObligationsAssets	3000	USD
CY2014Q2	us-gaap	Defined Benefit Plan Amortization Of Prior Service Cost Credit DefinedBenefitPlanAmortizationOfPriorServiceCostCredit	0	USD
CY2013Q1	us-gaap	Defined Benefit Plan Amortization Of Prior Service Cost Credit DefinedBenefitPlanAmortizationOfPriorServiceCostCredit	0	USD
CY2014Q2	us-gaap	Defined Benefit Plan Actuarial Gain Loss DefinedBenefitPlanActuarialGainLoss	-6000	USD
CY2013Q1	us-gaap	Net Income Loss NetIncomeLoss	471000	USD
CY2014Q2	us-gaap	Net Income Loss NetIncomeLoss	-1359000	USD
CY2014Q2	us-gaap	Weighted Average Number Of Shares Common Stock Subject To Repurchase Or Cancellation WeightedAverageNumberOfSharesCommonStockSubjectToRepurchaseOrCancellation	38116000	shares
CY2014Q2	us-gaap	Weighted Average Number Of Shares Restricted Stock WeightedAverageNumberOfSharesRestrictedStock	322000	shares
CY2014Q2	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	37794000	shares
CY2014Q2	us-gaap	Incremental Common Shares Attributable To Share Based Payment Arrangements IncrementalCommonSharesAttributableToShareBasedPaymentArrangements	0	shares
CY2013Q1	us-gaap	Incremental Common Shares Attributable To Share Based Payment Arrangements IncrementalCommonSharesAttributableToShareBasedPaymentArrangements	522000	shares
CY2013Q1	us-gaap	Incremental Common Shares Attributable To Call Options And Warrants IncrementalCommonSharesAttributableToCallOptionsAndWarrants	400000	shares
CY2013Q1	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	37418000	shares
CY2013Q1	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	0.01
CY2013Q1	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	0.01
CY2013Q1	us-gaap	Sales Revenue Net SalesRevenueNet	18001000	USD
CY2013Q1	us-gaap	Cost Of Goods And Services Sold CostOfGoodsAndServicesSold	5347000	USD
CY2013Q1	us-gaap	Gross Profit GrossProfit	12654000	USD
CY2013Q1	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	3958000	USD
CY2013Q1	us-gaap	Selling And Marketing Expense SellingAndMarketingExpense	5286000	USD
CY2014Q2	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	3484000	USD
CY2013Q1	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	1366000	USD
CY2013Q1	staa	Medical Device Tax MedicalDeviceTax	59000	USD
CY2013Q1	us-gaap	Other General Expense OtherGeneralExpense	901000	USD
CY2013Q1	us-gaap	Operating Income Loss OperatingIncomeLoss	1084000	USD
CY2013Q1	us-gaap	Investment Income Interest InvestmentIncomeInterest	35000	USD
CY2013Q1	us-gaap	Interest Expense InterestExpense	83000	USD
CY2013Q1	us-gaap	Foreign Currency Transaction Gain Loss Before Tax ForeignCurrencyTransactionGainLossBeforeTax	-341000	USD
CY2013Q1	us-gaap	Other Nonoperating Income OtherNonoperatingIncome	90000	USD
CY2013Q1	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	-299000	USD
CY2013Q1	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	785000	USD
CY2013Q1	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	314000	USD
CY2014Q2	us-gaap	Entity Wide Disclosure On Geographic Areas Description Of Revenue From External Customers EntityWideDisclosureOnGeographicAreasDescriptionOfRevenueFromExternalCustomers	The Company markets and sells its products in over 60 countries and has manufacturing sites in the United States and Switzerland. Other than the United States, Japan, Korea, China, and Spain the Company does not conduct business in any country in which its sales exceed 5% of consolidated sales. Sales are generally attributed to countries based on location of customers.100% of the Company’s sales are generated from the ophthalmic surgical product segment and therefore the Company operates as one operating segment for financial reporting purposes.
CY2014Q2	us-gaap	Number Of Countries In Which Entity Operates NumberOfCountriesInWhichEntityOperates	60	pure
CY2014Q2	staa	Segment Sales To Consolidated Sales Percentage SegmentSalesToConsolidatedSalesPercentage	1	pure
CY2014Q2	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	797000	USD
CY2014Q2	us-gaap	Restricted Stock Expense RestrictedStockExpense	293000	USD
CY2013Q1	us-gaap	Restricted Stock Expense RestrictedStockExpense	188000	USD
CY2014Q2	staa	Consultant Compensation ConsultantCompensation	22000	USD
CY2013Q1	staa	Consultant Compensation ConsultantCompensation	25000	USD
CY2014Q2	staa	Compensation Cost Total CompensationCostTotal	1500000	USD
CY2013Q1	staa	Compensation Cost Total CompensationCostTotal	1034000	USD
CY2014Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate	0	pure
CY2013Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate	0	pure
CY2014Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate	0.5525	pure
CY2013Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate	0.7344	pure
CY2014Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate	0.0128	pure
CY2014Q2	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Fair Value Assumptions Expected Term1 SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1	P4Y1M13D
CY2013Q1	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Fair Value Assumptions Expected Term1 SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1	P4Y1M13D
CY2014Q2	staa	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Term Of Options Granted ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedTermOfOptionsGranted	P15Y
CY2014Q1	us-gaap	Restructuring Reserve RestructuringReserve	759000	USD
CY2014Q2	us-gaap	Restructuring Charges RestructuringCharges	168000	USD
CY2014Q2	us-gaap	Payments For Restructuring PaymentsForRestructuring	78000	USD
CY2014Q2	us-gaap	Restructuring Reserve RestructuringReserve	849000	USD
CY2014Q2	staa	Estimated Cost Of Project EstimatedCostOfProject	6100000	USD
CY2014Q2	staa	Cost Of Project CostOfProject	168000	USD
CY2014Q2	staa	Estimated Cost Of Project Capital EstimatedCostOfProjectCapital	100000	USD
CY2014Q2	us-gaap	Operating Loss Carryforwards OperatingLossCarryforwards	122000000	USD
CY2014Q2	us-gaap	Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax	11000	USD
CY2013Q1	us-gaap	Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax	-672000	USD
CY2014Q2	us-gaap	Other Comprehensive Income Loss Net Of Tax OtherComprehensiveIncomeLossNetOfTax	2000	USD
CY2013Q1	us-gaap	Other Comprehensive Income Loss Net Of Tax OtherComprehensiveIncomeLossNetOfTax	-675000	USD
CY2014Q2	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	-1357000	USD
CY2013Q1	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	-204000	USD
CY2014Q2	us-gaap	Depreciation Depreciation	453000	USD
CY2013Q1	us-gaap	Depreciation Depreciation	369000	USD
CY2014Q2	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	106000	USD
CY2013Q1	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	117000	USD
CY2014Q2	us-gaap	Deferred Income Tax Expense Benefit DeferredIncomeTaxExpenseBenefit	24000	USD
CY2013Q1	us-gaap	Deferred Income Tax Expense Benefit DeferredIncomeTaxExpenseBenefit	7000	USD
CY2014Q2	us-gaap	Fair Value Adjustment Of Warrants FairValueAdjustmentOfWarrants	0	USD
CY2013Q1	us-gaap	Fair Value Adjustment Of Warrants FairValueAdjustmentOfWarrants	-27000	USD
CY2014Q2	us-gaap	Gain Loss On Disposition Of Assets GainLossOnDispositionOfAssets	0	USD
CY2013Q1	us-gaap	Gain Loss On Disposition Of Assets GainLossOnDispositionOfAssets	28000	USD
CY2014Q2	us-gaap	Increase Decrease In Pension Plan Obligations IncreaseDecreaseInPensionPlanObligations	45000	USD
CY2013Q1	us-gaap	Increase Decrease In Pension Plan Obligations IncreaseDecreaseInPensionPlanObligations	58000	USD
CY2014Q2	us-gaap	Share Based Compensation ShareBasedCompensation	1500000	USD
CY2013Q1	us-gaap	Share Based Compensation ShareBasedCompensation	1034000	USD
CY2014Q2	us-gaap	Asset Retirement Obligation Accretion Expense AssetRetirementObligationAccretionExpense	1000	USD
CY2013Q1	us-gaap	Asset Retirement Obligation Accretion Expense AssetRetirementObligationAccretionExpense	5000	USD
CY2014Q2	us-gaap	Other Noncash Income Expense OtherNoncashIncomeExpense	55000	USD
CY2013Q1	us-gaap	Other Noncash Income Expense OtherNoncashIncomeExpense	-27000	USD
CY2014Q2	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	295000	USD
CY2013Q1	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	322000	USD
CY2014Q2	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	1137000	USD
CY2013Q1	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	-288000	USD
CY2014Q2	staa	Increase Decrease In Prepaid Expenses Deposits And Other Assets Current IncreaseDecreaseInPrepaidExpensesDepositsAndOtherAssetsCurrent	1270000	USD
CY2013Q1	staa	Increase Decrease In Prepaid Expenses Deposits And Other Assets Current IncreaseDecreaseInPrepaidExpensesDepositsAndOtherAssetsCurrent	581000	USD
CY2014Q2	us-gaap	Increase Decrease In Accounts Payable IncreaseDecreaseInAccountsPayable	-610000	USD
CY2013Q1	us-gaap	Increase Decrease In Accounts Payable IncreaseDecreaseInAccountsPayable	-1328000	USD
CY2014Q2	us-gaap	Increase Decrease In Other Current Liabilities IncreaseDecreaseInOtherCurrentLiabilities	3000	USD
CY2013Q1	us-gaap	Increase Decrease In Other Current Liabilities IncreaseDecreaseInOtherCurrentLiabilities	-522000	USD
CY2014Q2	us-gaap	Net Cash Provided By Used In Operating Activities Continuing Operations NetCashProvidedByUsedInOperatingActivitiesContinuingOperations	-2594000	USD
CY2013Q1	us-gaap	Net Cash Provided By Used In Operating Activities Continuing Operations NetCashProvidedByUsedInOperatingActivitiesContinuingOperations	-432000	USD
CY2014Q2	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	1414000	USD
CY2013Q1	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	1218000	USD
CY2014Q2	us-gaap	Net Cash Provided By Used In Investing Activities Continuing Operations NetCashProvidedByUsedInInvestingActivitiesContinuingOperations	-1414000	USD
CY2013Q1	us-gaap	Net Cash Provided By Used In Investing Activities Continuing Operations NetCashProvidedByUsedInInvestingActivitiesContinuingOperations	-1218000	USD
CY2014Q2	us-gaap	Repayments Of Long Term Capital Lease Obligations RepaymentsOfLongTermCapitalLeaseObligations	46000	USD
CY2013Q1	us-gaap	Repayments Of Long Term Capital Lease Obligations RepaymentsOfLongTermCapitalLeaseObligations	242000	USD
CY2014Q2	us-gaap	Proceeds From Stock Options Exercised ProceedsFromStockOptionsExercised	2188000	USD
CY2013Q1	us-gaap	Proceeds From Stock Options Exercised ProceedsFromStockOptionsExercised	23000	USD
CY2014Q2	us-gaap	Net Cash Provided By Used In Financing Activities Continuing Operations NetCashProvidedByUsedInFinancingActivitiesContinuingOperations	2142000	USD
CY2013Q1	us-gaap	Net Cash Provided By Used In Financing Activities Continuing Operations NetCashProvidedByUsedInFinancingActivitiesContinuingOperations	-219000	USD
CY2014Q2	us-gaap	Effect Of Exchange Rate On Cash And Cash Equivalents EffectOfExchangeRateOnCashAndCashEquivalents	-18000	USD
CY2013Q1	us-gaap	Effect Of Exchange Rate On Cash And Cash Equivalents EffectOfExchangeRateOnCashAndCashEquivalents	-563000	USD
CY2014Q2	us-gaap	Cash And Cash Equivalents Period Increase Decrease CashAndCashEquivalentsPeriodIncreaseDecrease	-1884000	USD
CY2013Q1	us-gaap	Cash And Cash Equivalents Period Increase Decrease CashAndCashEquivalentsPeriodIncreaseDecrease	-2432000	USD
CY2012Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	21675000	USD
CY2013Q1	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	19243000	USD
CY2014Q2	dei	Document Type DocumentType	10-Q
CY2014Q2	dei	Amendment Flag AmendmentFlag	false
CY2014Q2	dei	Document Period End Date DocumentPeriodEndDate	2014-04-04
CY2014Q2	dei	Document Fiscal Year Focus DocumentFiscalYearFocus	2014
CY2014Q2	dei	Document Fiscal Period Focus DocumentFiscalPeriodFocus	Q1
CY2014Q2	dei	Trading Symbol TradingSymbol	STAA
CY2014Q2	dei	Entity Common Stock Shares Outstanding EntityCommonStockSharesOutstanding	38391311	shares
CY2014Q2	dei	Entity Registrant Name EntityRegistrantName	STAAR SURGICAL CO
CY2014Q2	dei	Entity Central Index Key EntityCentralIndexKey	0000718937
CY2014Q2	dei	Current Fiscal Year End Date CurrentFiscalYearEndDate	--01-03
CY2014Q2	dei	Entity Filer Category EntityFilerCategory	Accelerated Filer
CY2014Q2	us-gaap	Prior Period Reclassification Adjustment Description PriorPeriodReclassificationAdjustmentDescription	<div style="MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif "> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif" align="justify"><i>Prior Year Reclassifications</i></div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;TEXT-INDENT: 0.5in; MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif" align="justify"> </div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;TEXT-INDENT: 0.25in; MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif" align="justify">Certain reclassifications have been made to the prior periods’ unaudited condensed financial statements and related note disclosures to conform to current period’s presentation.</div> </div><table border="0" style="width:100%; table-layout:fixed;" cellspacing="0" cellpadding="0"><tr><td></td></tr></table>
CY2014Q2	us-gaap	Class Of Warrant Or Right Outstanding ClassOfWarrantOrRightOutstanding	700000	shares
CY2014Q1	staa	Warrants And Rights Exercisable WarrantsAndRightsExercisable	700000	shares
CY2014Q2	us-gaap	Defined Benefit Plan Fair Value Of Plan Assets Period Increase Decrease DefinedBenefitPlanFairValueOfPlanAssetsPeriodIncreaseDecrease	-11000	USD
CY2013Q1	us-gaap	Defined Benefit Plan Fair Value Of Plan Assets Period Increase Decrease DefinedBenefitPlanFairValueOfPlanAssetsPeriodIncreaseDecrease	-11000	USD
CY2014Q2	us-gaap	Other Comprehensive Income Loss Pension And Other Postretirement Benefit Plans Adjustment Before Reclassification Adjustments And Tax OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentBeforeReclassificationAdjustmentsAndTax	-6000	USD
CY2013Q1	us-gaap	Other Comprehensive Income Loss Pension And Other Postretirement Benefit Plans Adjustment Before Reclassification Adjustments And Tax OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentBeforeReclassificationAdjustmentsAndTax	-8000	USD
CY2014Q2	us-gaap	Other Comprehensive Income Loss Tax OtherComprehensiveIncomeLossTax	4000	USD
CY2013Q1	us-gaap	Other Comprehensive Income Loss Tax OtherComprehensiveIncomeLossTax	0	USD
CY2014Q1	us-gaap	Prepaid Expense Current PrepaidExpenseCurrent	2157000	USD
CY2014Q2	us-gaap	Prepaid Expense Current PrepaidExpenseCurrent	2820000	USD
CY2014Q1	us-gaap	Deferred Costs Current DeferredCostsCurrent	362000	USD
CY2014Q2	us-gaap	Deferred Costs Current DeferredCostsCurrent	280000	USD
CY2014Q2	staa	Percentage Of Other Current Liabilities PercentageOfOtherCurrentLiabilities	0.05	pure
CY2014Q1	us-gaap	Accrued Sales Commission Current AccruedSalesCommissionCurrent	528000	USD
CY2014Q2	us-gaap	Accrued Sales Commission Current AccruedSalesCommissionCurrent	229000	USD
CY2014Q2	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	2798000	shares

Files In Submission

Name	View Source	Status
0001144204-14-029780-index-headers.html	Edgar Link	pending
0001144204-14-029780-index.html	Edgar Link	pending
0001144204-14-029780.txt	Edgar Link	pending
0001144204-14-029780-xbrl.zip	Edgar Link	pending
FilingSummary.xml	Edgar Link	unprocessable
Financial_Report.xls	Edgar Link	pending
Financial_Report.xlsx	Edgar Link	pending
R1.htm	Edgar Link	pending
R10.htm	Edgar Link	pending
R11.htm	Edgar Link	pending
R12.htm	Edgar Link	pending
R13.htm	Edgar Link	pending
R14.htm	Edgar Link	pending
R15.htm	Edgar Link	pending
R16.htm	Edgar Link	pending
R17.htm	Edgar Link	pending
R18.htm	Edgar Link	pending
R19.htm	Edgar Link	pending
R2.htm	Edgar Link	pending
R20.htm	Edgar Link	pending
R21.htm	Edgar Link	pending
R22.htm	Edgar Link	pending
R23.htm	Edgar Link	pending
R24.htm	Edgar Link	pending
R25.htm	Edgar Link	pending
R26.htm	Edgar Link	pending
R27.htm	Edgar Link	pending
R28.htm	Edgar Link	pending
R29.htm	Edgar Link	pending
R3.htm	Edgar Link	pending
R30.htm	Edgar Link	pending
R31.htm	Edgar Link	pending
R32.htm	Edgar Link	pending
R33.htm	Edgar Link	pending
R34.htm	Edgar Link	pending
R35.htm	Edgar Link	pending
R36.htm	Edgar Link	pending
R37.htm	Edgar Link	pending
R38.htm	Edgar Link	pending
R39.htm	Edgar Link	pending
R4.htm	Edgar Link	pending
R40.htm	Edgar Link	pending
R41.htm	Edgar Link	pending
R42.htm	Edgar Link	pending
R43.htm	Edgar Link	pending
R44.htm	Edgar Link	pending
R45.htm	Edgar Link	pending
R46.htm	Edgar Link	pending
R47.htm	Edgar Link	pending
R48.htm	Edgar Link	pending
R49.htm	Edgar Link	pending
R5.htm	Edgar Link	pending
R6.htm	Edgar Link	pending
R7.htm	Edgar Link	pending
R8.htm	Edgar Link	pending
R9.htm	Edgar Link	pending
report.css	Edgar Link	pending
Show.js	Edgar Link	pending
staa-20140404.xml	Edgar Link	completed
staa-20140404.xsd	Edgar Link	pending
staa-20140404_cal.xml	Edgar Link	unprocessable
staa-20140404_def.xml	Edgar Link	unprocessable
staa-20140404_lab.xml	Edgar Link	unprocessable
staa-20140404_pre.xml	Edgar Link	unprocessable
v377545_10q.htm	Edgar Link	pending
v377545_ex10-98.htm	Edgar Link	pending
v377545_ex31-1.htm	Edgar Link	pending
v377545_ex31-2.htm	Edgar Link	pending
v377545_ex32-1.htm	Edgar Link	pending

Create your account

Find Stocks Worth Researching

Deeply Understand Businesses

Value Businesses Intelligently

$STAA
STAAR Surgical Co Stock $staa

2014 Q2 Form 10-Q Financial Statement

#000114420414029780 Filed on May 13, 2014

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$STAA STAAR Surgical Co Stock $staa

2014 Q2 Form 10-Q Financial Statement

#000114420414029780 Filed on May 13, 2014

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$STAA
STAAR Surgical Co Stock $staa